- Home
- MNTK vs ORIC Comparison
MNTK vs ORIC Comparison
Compare MNTK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- ORIC
- Stock Information
- Founded
- MNTK 1980
- ORIC 2014
- Country
- MNTK United States
- ORIC United States
- Employees
- MNTK N/A
- ORIC N/A
- Industry
- MNTK Natural Gas Distribution
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- ORIC Health Care
- Exchange
- MNTK Nasdaq
- ORIC Nasdaq
- Market Cap
- MNTK 339.0M
- ORIC 362.9M
- IPO Year
- MNTK 2021
- ORIC 2020
- Fundamental
- Price
- MNTK $2.13
- ORIC $10.82
- Analyst Decision
- MNTK Hold
- ORIC Strong Buy
- Analyst Count
- MNTK 3
- ORIC 9
- Target Price
- MNTK $3.33
- ORIC $18.29
- AVG Volume (30 Days)
- MNTK 215.6K
- ORIC 964.9K
- Earning Date
- MNTK 08-07-2025
- ORIC 08-11-2025
- Dividend Yield
- MNTK N/A
- ORIC N/A
- EPS Growth
- MNTK N/A
- ORIC N/A
- EPS
- MNTK 0.05
- ORIC N/A
- Revenue
- MNTK $179,552,000.00
- ORIC N/A
- Revenue This Year
- MNTK $2.49
- ORIC N/A
- Revenue Next Year
- MNTK $26.02
- ORIC N/A
- P/E Ratio
- MNTK $41.66
- ORIC N/A
- Revenue Growth
- MNTK N/A
- ORIC N/A
- 52 Week Low
- MNTK $1.68
- ORIC $3.90
- 52 Week High
- MNTK $6.13
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MNTK 47.04
- ORIC 66.82
- Support Level
- MNTK $2.22
- ORIC $10.42
- Resistance Level
- MNTK $2.78
- ORIC $11.50
- Average True Range (ATR)
- MNTK 0.19
- ORIC 0.62
- MACD
- MNTK -0.02
- ORIC -0.03
- Stochastic Oscillator
- MNTK 27.38
- ORIC 83.30
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.